|Not all subjects
failing MVC treatment with CCR5-tropic virus had phenotypic markers of MVC.
|•Seven of the subjects receiving MVC did not show phenotypic
markers of MVC resistance in the Monogram assay
|•The majority of these subjects (5/7) had evidence of
reduced susceptibility to one or more drugs within their OBT at screening
and/or at failure.
|•CCR5 receptor genotype should be examined from these
subjects to see if MVC can bind to these receptors